Cantargia: Orphan Drug Designation for CAN04 in Pancreatic Cancer in the US - Redeye
Redeye has a positive view of Cantargia's obtaining orphan drug status. It provides some benefits, the most important of which are described in our comment.
ANNONS
Redeye has a positive view of Cantargia's obtaining orphan drug status. It provides some benefits, the most important of which are described in our comment.